Severe acute pancreatitis is the most dangerous type of acute pancreatitis, often leading to multiple organ failure and systemic inflammatory response syndrome. In recent years, the incidence rate of severe acute pancreatitis has gradually increased, and the mortality rate is high. Early diagnosis and treatment are particularly important for reducing the risk of death in patients with severe acute pancreatitis. This article reviews the latest research progress in the diagnosis and treatment of severe acute pancreatitis in recent years.

1..Werge M, Novovic S, Schmidt PN, et al. Infection increases mortality in necrotizing pancreatitis: a systematic review and meta-analysis[J]. Pancreatology, 2016, 16(5): 698-707. DOI: 10.1016/j.pan.2016.07.004.

2..Boxhoorn L, Voermans RP, Bouwense SA, et al. Acute pancreatitis[J]. Lancet. 2020, 396(10252): 726-734. DOI: 10.1016/S0140-6736(20)31310-6.

3..Zilio MB, Eyff TF, Azeredo-Da-Silva ALF, et al. A systematic review and meta-analysis of the aetiology of acute pancreatitis[J]. HPB (Oxford), 2019, 21(3): 259-267. DOI: 10.1016/j.hpb.2018.08.003.

4..张娜, 张海燕, 郭晓红, 等. 中国近十年急性胰腺炎病因变化特点的Meta分析[J]. 中华消化病与影像杂志(电子版), 2016, 6(2): 71-75. [Zhang N, Zhang HY, Guo XH, et al. Changes of etiology in acute pancreatitis in re-cent 10 years in China: meta-analysis[J]. Chinese Journal of Digestion and Medical Imageolo-gy(Electronic Edition), 2016, 6(2): 71-75.] DOI: 10.3877/cma.j.issn.2095-2015.2016.02.006.

5..Wang J, Wang L, Zhang X, et al. Cathepsin B aggravates acute pancreatitis by activating the NLRP3 inflammasome and promoting the caspase-1-induced pyroptosis[J]. International Immunopharma-cology, 2021, 94: 107496. DOI: 10.1016/j.intimp.2021.107496.

6..Wu X, Yang Z, Wang H, et al. High-mobility group box protein-1 induces acute pancreatitis through activation of neutrophil extracellular trap and subsequent production of IL-1β[J]. Life Sci, 2021, 286: 119231. DOI: 10.1016/j.lfs.2021.119231.

7..Dai J, Jiang M, Hu Y, et al. Dysregulated SREBP1c/miR-153 signaling induced by hypertriglyceridemia worsens acute pancreatitis and delays tissue repair[J]. JCI Insight, 2021, 6(2): e138584. DOI: 10.1172/jci.insight.138584.

8..Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis—2012: revision of the Atlanta classifica-tion and definitions by international consensus[J]. Gut, 2013, 62(1): 102-111. DOI: 10.1136/gutjnl-2012-302779.

9..Colvin SD, Smith EN, Morgan DE, et al. Acute pancreatitis: an update on the revised Atlanta classifica-tion[J]. Abdom Radiol (NY), 2020, 45(5): 1222-1231. DOI: 10.1007/s00261-019-02214-w.

10..Gurusamy KS, Debray TP, Rompianesi G. Prognostic models for predicting the severity and mortality in people with acute pancreatitis[J]. Cochrane Database Syst Rev, 2018, 2018: CD013026. DOI: 10.1002/14651858.CD013026.

11..Fei Y, Gao K, Tu J, et al. Predicting and evaluation the severity in acute pancreatitis using a new mod-eling built on body mass index and intra-abdominal pressure[J]. The Am J Surg, 2018, 216(2): 304-309. DOI: 10.1016/j.amjsurg.2017.04.017.

12..Mahmoudi S, Martin S, Koch V, et al. Value of dual-energy CT perfusion analysis in patients with acute pancreatitis: correlation and discriminative diagnostic accuracy with varying disease severity[J]. Diag-nostics (Basel), 2022, 12(11): 2601. DOI: 10.3390/diagnostics12112601.

13..İnce AT, Silahtaroğlu G, Seven G, et al. Early prediction of the severe course, survival, and ICU re-quirements in acute pancreatitis by artificial intelligence[J]. Pancreatology, 2022, 23(2): 176-186. DOI: 10.1016/j.pan.2022.12.005.

14..Zhou Y, Ge YT, Shi XL, et al. Machine learning predictive models for acute pancreatitis: a systematic review[J]. Int J Med Inform, 2022, 157: 104641. DOI: 10.1016/j.ijmedinf.2021.104641.

15..Machicado JD, Papachristou GI. Intravenous fluid resuscitation in the management of acute pancreati-tis[J]. Curr Opin Gastroenterol, 2020, 36(5): 409-416. DOI: 10.1097/MOG.0000000000000659.

16..Besselink M, van Santvoort H, Freeman M, et al. IAP/APA evidence-based guidelines for the manage-ment of acute pancreatitis[J]. Pancreatology, 2013, 13(4, suppl 2): e1-e15. DOI: 10.1016/j.pan.2013.07.063.

17..Crockett SD, Wani S, Gardner TB, et al. American Gastroenterological Association Institute guideline on initial management of acute pancreatitis[J]. Gastroenterology, 2018, 154(4): 1096-1101. DOI: 10.1053/j.gastro.2018.01.032.

18..de-Madaria E, Buxbaum JL, Maisonneuve P, et al. Aggressive or moderate fluid resuscitation in acute pancreatitis[J]. N Engl J Med, 2022, 387(11): 989-1000. DOI: 10.1056/NEJMoa2202884.

19..Mourad MM, Evans R, Kalidindi V, et al. Prophylactic antibiotics in acute pancreatitis: endless de-bate[J]. Ann R Coll Surg Engl, 2017, 99(2): 107-112. DOI: 10.1308/rcsann.2016.0355.

20..Jafri NS, Mahid SS, Idstein SR, et al. Antibiotic prophylaxis is not protective in severe acute pancreati-tis: a systematic review and meta-analysis[J]. Am J Surg, 2009, 197(6): 806-813. DOI: 10.1016/j.amjsurg.2008.08.016.

21..Reuken PA, Albig H, Rödel J, et al. Fungal infections in patients with infected pancreatic necrosis and pseudocysts: risk factors and outcome[J]. Pancreas, 2018, 47(1): 92-98. DOI: 10.1097/MPA.0000000000000965.

22..Vege SS, DiMagno MJ, Forsmark CE, et al. Initial medical treatment of acute pancreatitis: American Gastroenterological Association Institute technical review[J]. Gastroenterology, 2018, 154, (4): 1103-1139. DOI: 10.1053/j.gastro.2018.01.031.

23..Leppäniemi A, Tolonen M, Tarasconi A, et al. 2019 WSES guidelines for the management of severe acute pancreatitis[J]. World J Emerg Surg, 2019, 14: 27. DOI: 10.1186/s13017-019-0247-0.

24..Cai W, Liu F, Wen Y, et al. Pain management in acute pancreatitis: a systematic review and me-ta-analysis of randomised controlled trials[J]. Front Med (Lausanne), 2021, 8: 782151. DOI: 10.3389/fmed.2021.782151.

25..Barlass U, Dutta R, Cheema H, et al. Morphine worsens the severity and prevents pa-ncreatic regen-eration in mouse models of acute pancreatitis[J]. Gut, 2018, 67(4): 600-602. DOI: 10.1136/gutjnl-2017-313717.

26..Kim J, Tabner AJ, Johnson GD, et al. Increased risk of acute pancreatitis with codeine use in patients with a history of cholecystectomy[J]. Dig Dis Sci, 2020, 65(1): 292-300. DOI: 10.1007/s10620-019-05803-3.

27..Huang Z, Ma X, Jia X, et al. Prevention of severe acute pancreatitis with cyclooxygenase-2 inhibitors: a randomized controlled clinical trial[J]. Am J Gastroenterol, 2020, 115(3): 473-480. DOI: 10.14309/ajg.0000000000000529.

28..Jabaudon M, Belhadj-Tahar N, Rimmelé T, et al. Thoracic epidural analgesia and mortality in acute pancreatitis: a multicenter propensity analysis[J]. Crit Care Med, 2018, 46(3): e198-e205. DOI: 10.1097/CCM.0000000000002874.

29..Wu LM, Sankaran SJ, Plank LD, et al. Meta-analysis of gut barrier dysfunction in patients with acute pancreatitis[J]. Br J Surg, 2014, 101(13): 1644-1656. DOI: 10.1002/bjs.9665.

30..中华医学会外科学分会胰腺外科学组. 中国急性胰腺炎诊治指南(2021)[J]. 浙江实用医学, 2021, 26(6): 511-519, 535. [Pancreatic Surgery Group, Branch of Surgery, Chinese Medical Association. Chinese Guidelines for the diagnosis and treatment of acute pancreatitis (2021)[J]. Zhejiang Practical Medicine, 2021, 26(6): 511-519, 535.] DOI: 10.16794/j.cnki.cn33-1207/r.2021.06.003.

31..Hongyin L, Zhu H, Tao W, et al. Abdominal paracentesis drainage improves tolerance of enteral nutri-tion in acute pancreatitis: a randomized controlled trial[J]. Scand J Gastroenterol, 2017, 52(4): 389-395. DOI: 10.1080/00365521.2016.1276617.

32..Tenner S, Baillie J, DeWitt J, et al. American College of Gastroenterology guideline: management of acute pancreatitis[J]. Am J Gastroenterol, 2013, 108(9): 1400-1415. DOI: 10.1038/ajg.2013.218.

33..McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and Ameri-can Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)[J]. JPEN J Parenter Enteral Nutr, 2016, 40(2): 159-211. DOI: 10.1177/0148607115621863.

34..Arvanitakis M, Ockenga J, Bezmarevic M, et al. ESPEN guideline on clinical nutrition in acute and chronic pancreatitis[J]. Clin Nutr, 2020, 39(3): 612-631. DOI: 10.1016/j.clnu.2020.01.004.

35..Jabłońska B, Mrowiec S. Nutritional support in patients with severe acute pancreatitis-current stand-ards[J]. Nutrients, 2021, 13(5): 1498. DOI: 10.3390/nu13051498.

36..Ye Q, Zhang J, Ou X, et al. Efficacy and safety of three endoscopic techniques for small common bile duct stones (≤10 mm): a multicenter, retrospective, cohort study with propensity score matching[J]. Surg Endosc, 2023, 37(3): 1863-1869. DOI: 10.1007/s00464-022-09436-y.

37..Strand DS, Law RJ, Yang D, et al. AGA clinical practice update on the endoscopic approach to recurrent acute and chronic pancreatitis: expert review[J]. Gastroenterology, 2022, 163(4): 1107-1114. DOI: 10.1053/j.gastro.2022.07.079.

38..Abdelqader A, Kahaleh M. When ERCP fails: EUS-guided access to biliary and pancreatic ducts[J]. Dig Dis Sci, 2022, 67(5): 1649-1659. DOI: 10.1007/s10620-022-07423-w.

39..Krafft MR, Nasr JY. Anterograde endoscopic ultrasound-guided pancreatic duct drainage: a technical review[J]. Dig Dis Sci, 2019, 64(7): 1770-1781. DOI: 10.1007/s10620-019-05495-9.

40..高堃, 童智慧, 李维勤. 急性胰腺炎局部并发症的引流指征与时机[J].中华医学杂志, 2019(25): 1938-1941. [Gao K, Tong ZH, Li WQ. Surgical intervention of local complications in acute pancreatitis: indication and tim-ing[J]. National Medical Journal of China, 2019(25): 1938-1941.] DOI: 10.3760/cma.j.issn.0376-2491.2019.25.006.

41..Hollemans RA, Bakker OJ, Boermeester MA, et al. Superiority of step-up approach vs open necrosec-tomy in long-term follow-up of patients with necrotizing pancreatitis[J]. Gastroenterology, 2019, 156(4): 1016-1026. DOI: 10.1053/j.gastro.2018.10.045.

42..van Brunschot S, van Grinsven J, van Santvoort HC, et al. Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial[J]. Lancet, 2018, 391(10115): 51-58. DOI: 10.1016/S0140-6736(17)32404-2.

43..Baron TH, DiMaio CJ, Wang AY, et al. American Gastroenterological Association clinical practice update: management of pancreatic necrosis[J]. Gastroenterology, 2020, 158(1): 67-75. e1. DOI: 10.1053/j.gastro.2019.07.064.

44..Yang J, Chen YI, Friedland S, et al. Lumen-apposing stents versus plastic stents in the management of pancreatic pseudocysts: a large, comparative, international, multicenter study[J]. Endoscopy, 2019, 51(11): 1035-1043. DOI: 10.1055/a-0759-1353.

45..国家消化病临床医学研究中心（上海）, 中华医学会消化内镜学分会超声内镜学组, 中国医师协会胰腺病学专业委员会. 中国胰腺假性囊肿内镜诊治专家共识意见(2022年)[J]. 中华消化内镜杂志, 2022, 39(10): 765-777. [National Digestive Disease Clinical Medical Research Center (Shanghai), Ultrasound Endoscopy Group, Diges-tive Endoscopy Branch, Chinese Medical Association,  Pancreatology Professional Committee of the Chinese Medical Doctor Association. Chinese expert consensus on endoscopic diagnosis and treat-ment for pancreatic pseudocyst (2022)[J]. Chinese Journal of Digestive Endoscopy, 2022, 39(10): 765-777.] DOI: 10.3760/cma.j.cn115667-20220923-00141.

46..Ramai D, Facciorusso A, DeLuca M, et al. Adverse events associated with AXIOS stents: insights from the manufacturer and user facility device experience database[J]. Endoscopic Ultrasound, 2022, 11(3): 231-236. DOI: 10.4103/EUS-D-21-00096.

47..Binda C, Sbrancia M, La Marca M, et al. EUS-guided drainage using lumen apposing metal stent and percutaneous endoscopic necrosectomy as dual approach for the management of complex walled-off necrosis: a case report and a review of the literature[J]. World J Emerg Surg, 2021, 16(1): 28. DOI: 10.1186/s13017-021-00367-y.

48..Han SB, Chen D, Chen QY, et al. One-step laparoscopic pancreatic necrosectomy verse surgical step-up approach for infected pancreatic necrosis: a case-control study[J]. World J Emerg Med, 2022, 13(4): 274-282. DOI: 10.5847/wjem.j.1920-8642.2022.058.

49..Huang D, Li Q, Lu Z, et al. From "step-up" to "step-jump": a leap-forward intervention for infected ne-crotizing pancreatitis[J]. Chin Med J (Engl), 2021, 135(3): 285-287. DOI: 10.1097/CM9.0000000000001877.